Treace Medical Concepts, Inc. (TMCI) stock
TMCINasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 5/3031% below fair value
$4.31−0.04 (-0.92%)
Close on Nov 20, 2026Market cap $280.30MP/E –Yield –
Treace Medical Concepts free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Treace Medical Concepts's free cash flow for the twelve months ending Jun 30, 2026 was -$25.05M. For fiscal 2025 it was -$29.49M. The highest annual figure on record is -$5.56M in fiscal 2020.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$29.49M | – |
| FY2024 | Dec 31, 2024 | -$48.76M | – |
| FY2023 | Dec 31, 2023 | -$46.03M | – |
| FY2022 | Dec 31, 2022 | -$45.49M | – |
| FY2021 | Dec 31, 2021 | -$19.90M | – |
| FY2020 | Dec 31, 2020 | -$5.56M | – |
| FY2019 | Dec 31, 2019 | -$8.88M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$6.90M | – |
| Q1 FY2026 | Mar 31, 2026 | $4.18M | +537.9% |
| Q4 FY2025 | Dec 31, 2025 | -$10.42M | – |
| Q3 FY2025 | Sep 30, 2025 | -$11.90M | – |
| Q2 FY2025 | Jun 30, 2025 | -$7.82M | – |
| Q1 FY2025 | Mar 31, 2025 | $655.00K | – |
| Q4 FY2024 | Dec 31, 2024 | -$7.28M | – |
| Q3 FY2024 | Sep 30, 2024 | -$14.71M | – |
| Q2 FY2024 | Jun 30, 2024 | -$15.63M | – |
| Q1 FY2024 | Mar 31, 2024 | -$11.15M | – |
| Q4 FY2023 | Dec 31, 2023 | -$1.72M | – |
| Q3 FY2023 | Sep 30, 2023 | -$13.01M | – |
| Q2 FY2023 | Jun 30, 2023 | -$12.57M | – |
| Q1 FY2023 | Mar 31, 2023 | -$18.74M | – |
| Q4 FY2022 | Dec 31, 2022 | -$7.69M | – |
| Q3 FY2022 | Sep 30, 2022 | -$13.34M | – |
| Q2 FY2022 | Jun 30, 2022 | -$15.73M | – |
| Q1 FY2022 | Mar 31, 2022 | -$8.72M | – |
| Q4 FY2021 | Dec 31, 2021 | -$4.65M | -297.1% |
| Q3 FY2021 | Sep 30, 2021 | -$10.20M | – |
| Q2 FY2021 | Jun 30, 2021 | -$4.40M | – |
| Q1 FY2021 | Mar 31, 2021 | -$642.00K | – |
| Q4 FY2020 | Dec 31, 2020 | $2.36M | – |
| Q3 FY2020 | Sep 30, 2020 | -$4.26M | – |
| Q2 FY2020 | Jun 30, 2020 | -$2.09M | – |
| Q1 FY2020 | Mar 31, 2020 | -$1.57M | – |
See a number that looks wrong?